Risk of Substantial Intraocular Bleeding With Novel Oral Anticoagulants
نویسندگان
چکیده
منابع مشابه
Risk of Substantial Intraocular Bleeding With Novel Oral Anticoagulants: Systematic Review and Meta-analysis.
IMPORTANCE In noninferiority trials, novel oral anticoagulants (NOACs), also known as non-vitamin K oral anticoagulants, were at least noninferior to standard care in the prevention of most prothrombotic conditions. However, differences exist in the safety profile of antithrombotic drugs, and little is known about their intraocular bleeding risk. OBJECTIVE To evaluate the risk of substantial ...
متن کاملBleeding complications of targeted oral anticoagulants: what is the risk?
The vitamin K antagonists (VKAs) are a widely used class of agent to prevent thromboembolism. In recent years, numerous alternatives to VKAs have been developed, the target-specific oral anticoagulants (TSOACs), which are available in clinical practice. Currently available agents target thrombin and factor Xa. The most significant side effect of these agents, as with VKAs, is the development of...
متن کاملGastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management
Novel oral anticoagulants (NOACs), which include direct thrombin inhibitor (dabigatran) and direct factor Xa inhibitors (rivaroxaban, apixaban and edoxaban), are gaining popularity in the prevention of embolic stroke in non-valvular atrial fibrillation as well as in the prevention and treatment of venous thromboembolism. However, similar to traditional anticoagulants, NOACs have the side effect...
متن کاملProcoagulants for management of bleeding with the new oral anticoagulants.
doi:10.1160/TH13-05-0357 Thromb Haemost 2013; 110: 1 Insight on ▶Perzborn et al. Thromb Haemost 2013; 110: 162-172. Treatment guidelines give preference to new oral anticoagulants (NOACs) over warfarin for stroke prevention in patients with non-valvular atrial fibrillation (AF) because the NOACs are at least as effective as warfarin, but are associated with less life-threatening bleeding and do...
متن کاملBleeding complications from the direct oral anticoagulants
BACKGROUND Direct oral anticoagulants (DOACs) are now standard of care for the management of thromboembolic risk. A prevalent issue of concern is how to manage direct oral anticoagulant (DOAC)-associated bleeding for which there is no specific antidote available for clinical use. We conducted a retrospective case series to describe the Toronto, Canada multicenter experience with bleeding from d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAMA Ophthalmology
سال: 2015
ISSN: 2168-6165
DOI: 10.1001/jamaophthalmol.2015.0985